|
| A multicenter, single-arm, basket design, phase II study of NC-6004 plus gemcitabine in patients with advanced unresectable lung, biliary tract, or bladder cancer |
|
https://doi.org/10.18632/oncotarget.27684
Simona Ruxandra Volovat, Tudor-Eliade Ciuleanu, Piotr Koralewski, Juneko E. Grilley Olson, Adina Croitoru, Krassimir Koynov, Stefano Stabile, Giulio Cerea, Atsushi Osada, Iulian Bobe, Constantin Volovat
|
| 3105-3117 |
|
| Molecular profiling of melanoma brain metastases compared to primary cutaneous melanoma and to extracranial metastases |
|
https://doi.org/10.18632/oncotarget.27686
Gino K. In, Kelsey Poorman, Michelle Saul, Steven O’Day, Jeffrey M. Farma, Anthony J. Olszanski, Michael S. Gordon, Jacob S. Thomas, Burton Eisenberg, Lawrence Flaherty, Amy Weise, Steven Daveluy, Geoffrey Gibney, Michael B. Atkins, Ari Vanderwalde
|
| 3118-3128 |
|
| Carnosic acid increases sorafenib-induced inhibition of ERK1/2 and STAT3 signaling which contributes to reduced cell proliferation and survival of hepatocellular carcinoma cells |
|
https://doi.org/10.18632/oncotarget.27687
Xuening Wang, Priya Gupta, Yasmeen Jramne, Michael Danilenko, Dongfang Liu, George P. Studzinski
|
| 3129-3143 |
|
| Superior prognosis stratification for stage III colon cancer using log odds of positive lymph nodes (LODDS) compared to TNM stage classification: the Japanese study group for postoperative follow-up of colorectal cancer |
|
https://doi.org/10.18632/oncotarget.27692
Shimpei Ogawa, Michio Itabashi, Yoshiko Bamba, Masakazu Yamamoto, Kenichi Sugihara
|
| 3144-3152 |
|
| An integrative microenvironment approach for follicular lymphoma: roles of inflammatory cell subsets and immune-response polymorphisms on disease clinical course |
|
https://doi.org/10.18632/oncotarget.27698
Guilherme Rossi Assis-Mendonça, André Fattori, Rafael Malagoli Rocha, Gustavo Jacob Lourenço, Márcia Torresan Delamain, Suely Nonogaki, Vladmir Cláudio Cordeiro de Lima, Gisele Wally Braga Colleoni, Cármino Antonio de Souza, Fernando Augusto Soares, Carmen Silvia Passos Lima, José Vassallo
|
| 3153-3173 |
|
| The bromodomain inhibitor IBET-151 attenuates vismodegib-resistant esophageal adenocarcinoma growth through reduction of GLI signaling |
|
https://doi.org/10.18632/oncotarget.27699
Annamil Alvarez-Trotta, Zhiqiang Wang, Elena Shersher, Bin Li, Jun Long, Ines Lohse, Claes Wahlestedt, Wael El-Rifai, David J. Robbins, Anthony J. Capobianco
|
| 3174-3187 |
RAPAMYCIN PRESS ® is a registered trademark of Rapamycin Press LLCß
